EXCLUSIVE: Brits back sharing DNA for research
The main reason for not sharing DNA for drug research is the fear it could be used without knowledge for corporate gain
Read More
Tag: genetic profile
- Transgene completes randomisation in phase 2 trial of tg4050
- Bayer wins MHRA approval for Kerendia in heart failure
- Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb
- Kainova expands DT 7012 trial into Europe
- Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease
